Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to support basic science research, from early exploratory studies to therapeutic discovery and development, in novel biologically active viral and/or host RNAs involved in virology (including HIV biology) and immune regulation.

...

Apply Now | General CFAR | NIH Administrative Supplement Opportunity
VIEW the Full Supplement Application Instructions

This administrative supplement opportunity is to support innovative research projects, inter-CFAR meetings, and shared instrumentation that address key gaps in HIV/AIDS and will advance the field.

The NIH is interested in supplement applications from CFARs in the following areas:

1. Promoting...

Read about the "Ending the HIV Epidemic: A Plan for America" at HIV.gov 

The ATN welcomes ideas from the scientific community in the form of proposals for new studies which are consistent with the Network's mission and are not currently being planned or pursued elsewhere. The ATN also welcomes proposals from investigators who would like to use existing data and/or specimens collected during ATN studies to answer questions related to the HIV epidemic among US adolescents and young adults.

Investigators interested in proposing an ATN study should submit a protocol...

The CROI preliminary agenda is online and features the following Harvard-affiliated investigators giving oral presentations  – Drs. Galit Alter, Keith Reeves, Heather Ribaudo, Pilar Garcia Broncano, Kathleen Wirth, Julia L Marcus, Jennifer Furin, Zaza Ndhlovu,...

The Massachusetts Department of Public Health (MDPH) has detected an increase in newly diagnosed HIV infections among persons who inject drugs (PWID) in multiple areas across the Commonwealth. Recent HIV transmission is evidenced by several new cases diagnosed during the acute stage of HIV infection. The primary risk factor reported among identified cases is injection drug use (IDU). Injectable substances linked to this outbreak include heroin, fentanyl, and methamphetamine.

MDPH is asking healthcare providers to enhance their vigilance for, increase their testing of,...

We are delighted to announce a call for applications for the Sustained Training in Aging and HIV Research (STAHR) Program. This program aims to develop promising scientists into high quality independently-funded researchers whose long-term careers will make a lasting contribution to the area of HIV and aging mental health research,...